Literature DB >> 23685994

[Mental disorders in patients with fibromyalgia syndrome: screening in centres of different medical specialties].

A Galek1, B Erbslöh-Möller, V Köllner, H Kühn-Becker, J Langhorst, F Petermann, U Prothmann, A Winkelmann, W Häuser.   

Abstract

BACKGROUND: Systematic reviews have reported a wide range of prevalence rates for depressive, anxiety and posttraumatic stress disorders (PTSD) in patients with fibromyalgia syndrome (FMS) which have been partially explained by setting differences. No data are currently available on the prevalence of potential mental disorders depending on the medical specialty in Germany.
MATERIAL AND METHODS: All consecutive FMS patients of 8 study centres (3 rheumatology/orthopaedic surgery, 3 psychosomatic/pain medicine, 2 physical/integrative medicine) were assessed from February 1 to July 31, 2012 with standardised questionnaires. Patients with FMS diagnosed by a study physician were included. Non-German speaking and mentally retarded patients were excluded. The German version of the Patient Health Questionnaire 4 was used to screen for potential depressive and anxiety disorders. Severe life events were assessed by the trauma list of the Munich Composite International Diagnostic Interview and symptom criteria of PTSD of the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) using the Posttraumatic Diagnostic Scale.
RESULTS: Of 538 patients, 396 patients (93.9 % women, mean age 52.3 years, mean duration since chronic widespread pain 12.8 years, mean duration since FMS diagnosis 4.5 years) were analysed. In all, 65.7 % of patients met the criteria of a potential depressive disorder, 67.9 % of a potential anxiety disorder and 45.5 % of a potential PTSD. Potential depressive disorders were more frequent in the psychosomatic/pain medicine setting than in the rheumatology setting.
CONCLUSION: Potential mental disorders were frequent in FMS patients regardless of the medical specialty. All FMS patients of all types of clinical settings should be screened for mental disorders.

Entities:  

Mesh:

Year:  2013        PMID: 23685994     DOI: 10.1007/s00482-013-1323-0

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  31 in total

Review 1.  Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis.

Authors:  Winfried Häuser; Maria Kosseva; Nurcan Üceyler; Petra Klose; Claudia Sommer
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-06       Impact factor: 4.794

2.  Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia.

Authors:  Frederick Wolfe; Daniel J Clauw; Mary-Ann Fitzcharles; Don L Goldenberg; Winfried Häuser; Robert S Katz; Philip Mease; Anthony S Russell; I Jon Russell; John B Winfield
Journal:  J Rheumatol       Date:  2011-02-01       Impact factor: 4.666

3.  [Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].

Authors:  U Marschall; B Arnold; W Häuser
Journal:  Schmerz       Date:  2011-08       Impact factor: 1.107

4.  A comparison of the clinical features of fibromyalgia syndrome in different settings.

Authors:  Winfried Häuser; Werner Biewer; Mechthild Gesmann; Hedi Kühn-Becker; Frank Petzke; Hubertus von Wilmoswky; Jost Langhorst; Heide Glaesmer
Journal:  Eur J Pain       Date:  2011-06-08       Impact factor: 3.931

Review 5.  [Psychotherapy for patients with fibromyalgia syndrome. Systematic review, meta-analysis and guideline].

Authors:  V Köllner; W Häuser; K Klimczyk; H Kühn-Becker; M Settan; M Weigl; K Bernardy
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

6.  [Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis].

Authors:  W Eich; W Häuser; B Arnold; W Jäckel; M Offenbächer; F Petzke; M Schiltenwolf; M Settan; C Sommer; T Tölle; N Uçeyler; P Henningsen
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

7.  Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population.

Authors:  Frederick Wolfe; Elmar Brähler; Andreas Hinz; Winfried Häuser
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

8.  Diagnosis and differential diagnosis of fibromyalgia.

Authors:  Don L Goldenberg
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

9.  [Prevalence and predictors of pain in several body regions. Results of a representative German population survey].

Authors:  W Häuser; G Schmutzer; H Glaesmer; E Brähler
Journal:  Schmerz       Date:  2009-10       Impact factor: 1.107

10.  Feeling bad in more ways than one: comorbidity patterns of medically unexplained and psychiatric conditions.

Authors:  Ellen A Schur; Niloofar Afari; Helena Furberg; Megan Olarte; Jack Goldberg; Patrick F Sullivan; Dedra Buchwald
Journal:  J Gen Intern Med       Date:  2007-06       Impact factor: 5.128

View more
  6 in total

1.  Self-reported childhood maltreatment, lifelong traumatic events and mental disorders in fibromyalgia syndrome: a comparison of US and German outpatients.

Authors:  Winfried Häuser; Eva-Maria Hoffmann; Frederick Wolfe; Angus B Worthing; Neil Stahl; Russell Rothenberg; Brian Walitt
Journal:  Clin Exp Rheumatol       Date:  2015-03-18       Impact factor: 4.473

2.  Serum agrin and talin are increased in major depression while agrin and creatine phosphokinase are associated with chronic fatigue and fibromyalgia symptoms in depression.

Authors:  Hussein Kadhem Al-Hakeim; Ameer Abdul Razzaq Al-Issa; Michael Maes
Journal:  Metab Brain Dis       Date:  2019-11-16       Impact factor: 3.584

3.  [Aspects of liaison psychiatry care of patients in a university pain clinic].

Authors:  M Brinkers; G Pfau; C Schneemilch
Journal:  Schmerz       Date:  2018-04       Impact factor: 1.107

Review 4.  Psychological impact of fibromyalgia: current perspectives.

Authors:  Carmen M Galvez-Sánchez; Stefan Duschek; Gustavo A Reyes Del Paso
Journal:  Psychol Res Behav Manag       Date:  2019-02-13

Review 5.  Antipsychotics for fibromyalgia in adults.

Authors:  Brian Walitt; Petra Klose; Nurcan Üçeyler; Tudor Phillips; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2016-06-02

Review 6.  Oxidative Dysregulation in Early Life Stress and Posttraumatic Stress Disorder: A Comprehensive Review.

Authors:  Evangelos Karanikas; Nikolaos P Daskalakis; Agorastos Agorastos
Journal:  Brain Sci       Date:  2021-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.